台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    101.0
  • 漲跌
    ▲0.5
  • 漲幅
    +0.50%
  • 成交量
    25
  • 產業
    上櫃 文化創意指數
  • 105人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
智基 (6294)籌碼相關-第一金-豐原 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

第一金-豐原 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/06/241100.5000.00100.5011390.72%
2024/06/210101.0000.00100.5001400.02%
2024/06/190.1101.0000.00101.000.11430.03%
2024/05/2800.000.1103.00102.50-0.1158-0.06%
2024/05/2300.003102.50102.50-3157-1.90%
2024/05/2200.000.1104.00103.00-0.1157-0.03%
2024/05/2000.000.1104.50103.50-0.1154-0.03%
2024/05/175105.3000.00105.5051523.28%
2024/05/161106.5000.00107.0011500.67%
2024/05/1500.005103.30104.00-5148-3.37%
2024/05/145.2101.0200.00102.005.21443.59%
2024/05/130.2107.000107.00107.000.21270.15%
2024/05/100119.5000.00118.5001200.01%
2024/05/081.3118.1000.00118.001.31191.06%
2024/04/3000.000.5118.00118.00-0.5116-0.41%
2024/04/160.1114.5000.00114.000.11110.09%
2024/03/191121.5000.00123.001551.81%
2024/03/181123.0000.00124.001511.95%
2024/03/0700.000.2114.00114.00-0.234-0.44%
2024/02/2600.000.1112.50112.00-0.132-0.31%
2024/02/220.1112.5000.00112.000.1320.31%
2024/02/160.1112.0000.00111.500.1310.32%
2024/01/240.1111.0000.00110.500.1300.33%
2024/01/090.1112.0000.00112.500.1270.18%
2023/12/2600.000.1114.50114.50-0.124-0.35%
2023/11/130.2113.0000.00112.500.2210.95%
2023/10/170.2117.0000.00117.000.2240.61%
2023/10/120.4117.0000.00117.000.4251.39%
2023/10/060117.5000.00116.500250.18%
2023/10/050116.5000.00116.500250.16%
2023/10/040115.0000.00116.000250.05%
2023/09/1400.001114.00114.50-126-3.79%
2023/07/311112.0000.00111.501333.01%
2023/06/0100.000.3108.00108.50-0.355-0.45%
2023/05/0300.001109.00108.50-152-1.90%
2023/04/210.2108.5300.00108.000.2530.38%
2023/04/200.1109.0000.00109.000.1530.09%
2023/04/191110.0000.00109.001521.90%
2021/10/1200.001133.00132.50-137-2.61%
2019/09/0900.001102.50101.50-141-2.42%
2019/07/041102.0000.00102.001442.24%
2018/03/191128.0021127.02127.50-20176-11.33%
2018/01/1910128.0010124.00124.0001480.00%
2018/01/1520114.9800.00118.002011417.41%
2018/01/1200.004110.00110.00-4104-3.81%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音